International Journal of Clinical and Experimental Pathology

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Strategy of combining CDK4/6 inhibitors with other therapies and mechanisms of resistance

  Citation: 8

  Authors: Yingfei

• Prognostic impact of tumor-associated neutrophils in breast cancer

  Citation: 7

  Authors: Akinari

• Alpha-fetoprotein, glypican-3, and kininogen-1 as biomarkers for the diagnosis of hepatocellular carcinoma

  Citation: 4

  Authors: Diana Gabriela

• Significance of Nestin and CD133 as cancer stem cell markers in diffuse glioma and association with p53 expression and IDH status

  Citation: 4

  Authors: Sivaranjani

• Inhibition of bromodomain regulates cellular senescence in pancreatic adenocarcinoma

  Citation: 4

  Authors: Xiang

• Role of SLC31A1 in prognosis and immune infiltration in breast cancer: a novel insight

  Citation: 3

  Authors: Zhen-Hua

• miR-34b-5p suppresses the epithelial-mesenchymal transition and metastasis in endometrial cancer AN3CA cells by targeting ZEB1

  Citation: 2

  Authors: Lulu

• STAT1 as a potential therapeutic target to treat bladder cancer

  Citation: 2

  Authors: Qin

• Targeted biopsy added to systematic biopsy improves cancer detection in prostate cancer screening

  Citation: 2

  Authors: Peizi

• Correlation of LOXL2 expression in non-small cell lung cancer with immunotherapy

  Citation: 2

  Authors: Haoyan